UNIVERSAL EXERCISE UNIT and REBOUND THERAPY ON GENU RECURVATUM Cerebral Palsy Childeren

NCT ID: NCT07008521

Last Updated: 2025-06-06

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

ACTIVE_NOT_RECRUITING

Clinical Phase

NA

Total Enrollment

60 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-03-01

Study Completion Date

2025-10-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

to investigate and compare between effectiveness of Universal Exercise Unit and Rebound Therapy on genu recurvatum, muscle strength, balance, functional mobility and quality of life in spastic cerebral palsy children

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Children will be equally assigned into three groups using simple randomization, control group, study group (A) and study group (B). Each group will consist of 20 children with spastic CP to overcome any drop out may occur.

Control group: Children in this group will receive a traditional physical therapy program.

Study group (A): Children in this group will receive a traditional physical therapy program in addition to universal exercise unit program.

Study group (B): Children in this group will receive the same traditional physical therapy program in addition to rebound therapy.

Evaluation will be carried out for each child individually before and after 3 months of treatment.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Genu Recurvatum

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Participants Outcome Assessors
Participants will be assigned randomly into three groups of equal number (control group, study group A and study group B ) the randomization will be performed by simple randomization. Assessors will be blinded to the groups of the subjects.

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

control group

Control group: Children in this group will receive a traditional physical therapy program.

Group Type ACTIVE_COMPARATOR

Traditional physical therapy program

Intervention Type PROCEDURE

traditional physical therapy program for contrl group

study group A

Study group (A): Children in this group will receive a traditional physical therapy program in addition to universal exercise unit program.

Group Type EXPERIMENTAL

Universal exercise unit

Intervention Type PROCEDURE

universal exercise unit (UEU) for study groip (A)

Study group B

Study group (B): Children in this group will receive the same traditional physical therapy program in addition to rebound therapy

Group Type EXPERIMENTAL

Rebound Therapy

Intervention Type PROCEDURE

rebound therpay for study group (B)

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Universal exercise unit

universal exercise unit (UEU) for study groip (A)

Intervention Type PROCEDURE

Rebound Therapy

rebound therpay for study group (B)

Intervention Type PROCEDURE

Traditional physical therapy program

traditional physical therapy program for contrl group

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* -Children with spastic CP both hemiplegic and diplegic.
* Their ages will be ranged from 5-7 years old.
* They will have mild spasticity (grade 1 and 1+) according to Modified Ashworth scale .
* They will be in level I and II according to gross motor function classification system (GMFCS) .
* They will be able to understand orders given to them.

Exclusion Criteria

* Subjects will be excluded if they have the following:

1. Visual or hearing impairment.
2. Severe limb deformities as structural genurecurvatum.
3. Surgical interference in the lower limbs for the last 6 months.
4. Botulinum toxin injection of the spastic lower limb muscles during the last six months.
Minimum Eligible Age

5 Years

Maximum Eligible Age

7 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Cairo University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Merhan Megahid Hamouda Bakr

assistant lecturer

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Nanees Essam Mohamed, PhD

Role: STUDY_DIRECTOR

Cairo University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Faculty of Physical Therapy

Giza, , Egypt

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Egypt

Related Links

Access external resources that provide additional context or updates about the study.

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

012005355

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Pully System Exercise Role in Management of Spasticity
NCT06927869 ENROLLING_BY_INVITATION NA